ArticleAmerican journal of hematology2019
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.
Jennifer B Dunlap et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it